We are live on
!
Find out more
NERM
New England Research & Management Portfolio holdings
AUM
$257M
1-Year Est. Return
25.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.9%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$218M
AUM Growth
+$7.19M
(+3.4%)
Cap. Flow
-$6.19M
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
29.01%
Holding
178
New
31
Increased
32
Reduced
56
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$1.99M |
| 2 |
GE Vernova
GEV
|
+$1.94M |
| 3 |
Capital One
COF
|
+$1.52M |
| 4 |
Arrow Electronics
ARW
|
+$1.52M |
| 5 |
D.R. Horton
DHI
|
+$1.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$3.92M |
| 2 |
UnitedHealth
UNH
|
+$2.06M |
| 3 |
Toll Brothers
TOL
|
+$1.98M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.92M |
| 5 |
Fortinet
FTNT
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.6% |
| 2 | Technology | 15.11% |
| 3 | Healthcare | 14.51% |
| 4 | Financials | 12.59% |
| 5 | Consumer Discretionary | 12.05% |
Similar funds
GCCM
EBWM
HFRG
ACM
CCA
PHAM
TC
New England Research & Management's Q3 2025 Portfolio in Review
As of Q3 2025, New England Research & Management held 178 positions worth $218M, up 3.4% from $211M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
New England Research & Management's Q3 2025 filing shows 31 new, 32 increased, 56 reduced and 32 closed positions. Its largest new stake was lululemon athletica: 9,950 shares worth $1.77M. The largest sale was Goldman Sachs, an estimated $3.92M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.
- New England Research & Management's largest Q3 2025 buy was lululemon athletica: 9,950 shares worth $1.77M.
- New England Research & Management added most to GE Vernova in Q3 2025, an estimated $1.94M increase.
- New England Research & Management's biggest Q3 2025 reduction was Goldman Sachs, cutting an estimated $3.92M.
- New England Research & Management fully exited Teradyne in Q3 2025, selling an estimated $1.55M.
- New England Research & Management's ten largest holdings make up 29% of its $218M portfolio in Q3 2025.
- New England Research & Management opened 31 new positions and closed 32 in Q3 2025.
- New England Research & Management's portfolio value rose 3.4% quarter-over-quarter to $218M.
Based on New England Research & Management's 13F filing for Q3 2025, filed 6 Oct 2025.